Search

Your search keyword '"Antinori A."' showing total 935 results

Search Constraints

Start Over You searched for: Author "Antinori A." Remove constraint Author: "Antinori A." Topic business Remove constraint Topic: business
935 results on '"Antinori A."'

Search Results

1. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

2. Incidence of dyslipidemia in people with HIV who are treated with integrase inhibitors versus other antiretroviral agents

Catalog

Books, media, physical & digital resources

3. Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome

4. Arrhythmic safety of hydroxychloroquine in COVID-19 patients from different clinical settings

5. Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression

6. Cerebrospinal Fluid Viral Load Across the Spectrum of Untreated Human Immunodeficiency Virus Type 1 (HIV-1) Infection: A Cross-Sectional Multicenter Study

7. CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies

8. GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults

9. Three-year durable efficacy of dolutegravir plus lamivudine in antiretroviral therapy – naive adults with HIV-1 infection

10. Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial

11. Brief Report: Impact of the COVID-19 Pandemic on Virological Suppression in People Living With HIV Attending a Large Italian HIV Clinic

12. Impact, incidence and prevalence of musculoskeletal injuries in senior amateur male rugby: epidemiological study

13. In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy

14. Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study

15. The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort

16. C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age

17. HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects from the ICONA Italian Cohort of HIV-Infected Patients

18. Heparin in COVID-19 patients is associated with reduced in-hospital mortality: the multicentre Italian CORIST Study

19. Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering

20. Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males

21. Lopinavir/ritonavir and darunavir/cobicistat in hospitalized covid-19 patients: Findings from the multicenter italian corist study

22. Ceftazidime-avibactam use for klebsiella pneumoniae carbapenemase-producing k. pneumoniae infections: A retrospective observational multicenter study

23. Genetic mechanisms of critical illness in COVID-19

24. Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study

25. Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study

26. Evaluation of HIV-1 integrase resistance emergence and evolution in patients treated with integrase inhibitors

27. Tenofovir plasma trough concentrations in people with HIV treated with doravirine versus other antiretroviral regimens

28. Is the rate of virological failure to cART continuing to decline in recent calendar years?

29. Impact of gender on patients hospitalized for SARS‐COV‐2 infection: A prospective observational study

30. Drug–Drug Interactions and Prescription Appropriateness at Hospital Discharge: Experience with COVID-19 Patients

31. Time spent with HIV-RNA ≤ 200 copies/ml in a cohort of people with HIV during the U=U era

32. Spontaneous ilio-psoas haematomas (IPHs): a warning for COVID-19 inpatients

33. Oral anticoagulation and clinical outcomes in COVID-19: An Italian multicenter experience

34. Drug–Drug Interactions and Prescription Appropriateness in Patients with COVID-19: A Retrospective Analysis from a Reference Hospital in Northern Italy

35. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study

36. Unexpectedly High Frequency of Enterococcal Bloodstream Infections in Coronavirus Disease 2019 Patients Admitted to an Italian ICU: An Observational Study

37. Evolocumab in HIV-Infected Patients With Dyslipidemia

38. Effect of HIV-infection on QuantiFERON-plus accuracy in patients with active tuberculosis and latent infection

39. Embriopatía por virus Zika en Argentina: características clínicas y diagnóstico en recién nacidos

40. Impact of HCV Eradication on Lipid Metabolism in HIV/HCV Coinfected Patients: Data from ICONA and HepaICONA Foundation Cohort Study

41. Decrease in Incidence Rate of Hospitalizations Due to AIDS-Defining Conditions but Not to Non-AIDS Conditions in PLWHIV on cART in 2008-2018 in Italy

42. No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL

43. Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART

44. Case Report: A Fatal Case of West Nile Virus Meningoencephalomyelitis in a Woman with Systemic Lupus Erythematosus Initially Misdiagnosed as SARS-CoV-2 Infection

45. Risks of potential drug–drug interactions in COVID-19 patients treated with corticosteroids: a single-center experience

46. Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort

47. Evaluation of HIV transmission clusters among natives and foreigners living in Italy

48. Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?

49. RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies

50. Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data from the PRESTIGIO Registry